Remove 2029 Remove Manufacturing Remove Securities
article thumbnail

HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities

Global Newswire by Notified: M&A

These technologies include specialized equipment designed to increase both the total yield and the tryptamine profile of mushrooms by enabling the production of larger and more potent biomass for psychedelic drug manufacturing. VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc.